Technical Factors Involved in Parathyroid Surgery

Similar documents
Efficacy of intraoperative parathyroid hormone monitoring to predict success of parathyroidectomy for secondary hyperparathyroidism

Yueming Sun Æ Huihua Cai Æ Jianfeng Bai Æ Hanlin Zhao Æ Yi Miao

Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital

ORIGINAL ARTICLE. Novel Parathyroid Hormone (1-84) Assay as Basis for Parathyroid Hormone Monitoring in Renal Hyperparathyroidism

hypercalcemia of malignancy hyperparathyroidism PHPT the most common cause of hypercalcemia in the outpatient setting the second most common cause

HYPERPARATHYROIDIS M FAISAL GHANI SIDDIQUI MBBS; FCPS; PGDIP-BIOMEDICAL ETHICS; MCPS-HPE

Surgical anatomy of thyroid and parathyroid glands

SURGERY FOR RENAL HYPERPARATHYROIDISM - EXPERIENCE OF 640 CASES -

Total parathyroidectomy with autotransplantation in patients with renal hyperparathyroidism: indications and surgical approach

Parathyroid Imaging. A Guide to Parathyroid Surgery

Reoperative central neck surgery

HPI joint pain/arthritis serum calcium 11.5 PTH 147pg/ml

Thallium 201 scanning can diagnose multiple recurrences in forearm implanted parathyroid tissue post total parathyroidectomy:

Secondary and Familial Hyperparathyroidism

Near total parathyroidectomy for the treatment of renal hyperparathyroidism

Ultrasound examination in diagnosis of morphological variants of parathyroid hyperplasia in patients with secondary hyperparathyroidism

Title:Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism

Secondary Hyperparathyroidism: Where are we now?

Hyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012

Parathyroid Imaging: Current Concepts. Maria Gule-Monroe, M.D. Nancy Perrier, M.D.

PARATHYROID NUCLEAR MEDICINE IMAGING REVIEW DISCLOSURES

ORIGINAL ARTICLE. Long-term Results of Subtotal vs Total Parathyroidectomy Without Autotransplantation in Kidney Transplant Recipients

Ectopic intravagal parathyroid adenoma

Re-explorative Parathyroid Surgery for Persistent and Recurrent Primary Hyperparathyroidism

THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE

Case 2: 30 yr-old woman with 7 yr history of recurrent kidney stones

Stromal Fat Content of the Parathyroid Gland

PARATHYROID IMAGING. James Lee, MD Chief, Endocrine Surgery Co-Director NY Thyroid-Parathyroid Center Columbia University Medical Center

Outline. Parathyroid Localization Studies. Mira Milas MD, FACS Associate Professor of Surgery Director, The Thyroid Center

Outline. SPECT/CT in Parathyroid Disease. Pathophysiology. Current guidelines. SPECT/CT the evidence. SPECT/CT in clinical scenarios

Use of PTH at Point of Surgery for Non-Localized Cases of Hyperparathyoidism

Concurrent Renal Chronic Kidney Disease-Metabolic Bone Disorder (Renal Hyperparathyroidism) and Noninvasive Benign Thymoma

Outline. Primary Hyperparathyriodism. SPECT/CT in Parathyroid Localisation. Ann-Marie Quigley Nuclear Medicine Royal Free Hospital London

The parathyroid glands participate in the regulation

PRIMARY HYPERPARATHYROIDISM WITH RICKETS. KRITHIKA.P Dr.L.N.Padmasani Unit 1 Sri Ramachandra Medical College

DR. DARWISH H. BADRAN. Parathyroid glands

Case Report Use of Percutaneous Ethanol Injection Therapy for Recurrent Secondary Hyperparathyroidism after Subtotal Parathyroidectomy

Parathyroid Glands: location, condition and value of imaging tests.

The Laryngoscope. VC 2010 The American Laryngological, Rhinological and Otological Society, Inc.

Transient Thyrotoxicosis After Parathyroidectomy in a Hemodialysis Patient with Secondary Hyperparathyroidism

Sestamibi Scintigraphy, Topography, and Histopathology of Parathyroid Glands in Secondary Hyperparathyroidism

CKD: Bone Mineral Metabolism. Peter Birks, Nephrology Fellow

Persistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019

Potential conflicts of interest: None

PRIMARY HYPERPARATHYROIDISM

The relationship between parathyroid enlargement and parathyroid hormone levels in patients undergoing hemodialysis; EMR(Electronic Medical Record)

Kobe University Repository : Kernel

ORIGINAL ARTICLE. Appearance of Ectopic Undescended Inferior Parathyroid Adenomas on Technetium Tc 99m Sestamibi Scintigraphy

Medical and surgical aspects of parathyroidectomy

Minimally invasive parathyroidectomy

Therapeutic golas in the treatment of CKD-MBD

ORIGINAL ARTICLE. parathyroid graft function after presternal

Surgical management of secondary hyperparathyroidism in chronic kidney disease a consensus report of the European Society of Endocrine Surgeons

Primary hyperparathyroidism (HPT) has an incidence of

Clinical Approach to Hypercalcemia For the Primary Care Provider

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%

General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons

ORIGINAL ARTICLE. Incidental Parathyroidectomy During Thyroid Surgery Does Not Cause Transient Symptomatic Hypocalcemia

Thyroid & Parathyroid glands Ultrasound evaluation.

Sensipar. Sensipar (cinacalcet) Description

Hyperparathyroidism. When to Suspect, How to Diagnose, When and How to Intervene. Johanna A. Pallotta, MD, FACP, FACE

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release

SPECT/CT Fusion in the Diagnosis of Hyperparathyroidism

Endocrine University 2016 AACE-ACE-MAYO CLINIC

INDEX. Note: Page numbers of issue and article titles are in boldface type. cell carcinoma. ENDOCRINE SURGERY

Complementary sestamibi scintigraphy and ultrasound for primary hyperparathyroidism

ORIGINAL ARTICLE. An Optimal Algorithm for Intraoperative Parathyroid Hormone Monitoring

PTH > 60pg/ml PRIMARY HYPERPARATHYROIDISM. Introduction Biochemical Diagnosis. Normal Parathyroid. Parathyroid Glands

Women s Health in General Practice Symposium 2015 Thyroid & Parathyroid Cases

Corporate Presentation January 2013

Michael M. Krausz, Itamar Ashkenazi, Miri Bidder, and Rikardo Alfici Division of Surgery, Hillel Yaffe Medical Center and the Technion- Israel

Normal PTH Levels in Primary Hyperparathyroidism: Still the Same Disease?

Marcin Barczynski, 1 Aleksander Konturek, 2 Alicja Hubalewska-Dydejczyk, 2. Filip Gołkowski, 1 Stanislaw Cichon, 1 Piotr Richter, 1 Wojciech Nowak

Primary Hyperparathyroidism

Surgical Outcome of Patients with Hyperparathyroidism in a Non-Specialist Surgical Ward

27 Reoperative Parathyroid Surgery

Post-thyroidectomy Hypocalcemia in King Abdullah University Hospital and Princess Basma Teaching Hospital, Jordan

New technologies in Endocrine Surgery

4/20/2015. The Neck xt Exploration: Intraoperative Parathyroid Hormone (IOPTH) Testing During Surgical Parathyroidectomy. Learning Objectives

Health Sciences Centre, Team A, Dr. L. Bohacek (Endocrine Surgery) Medical Expert

Thyroid and Parathyroid Disease. RTC Conference Christina Edwards Bailey Faculty: Dr. Carmen Solorzano April 2, 2010

Ultrasound Evaluation of Hyperparathyroidism

of Human Parathyroid Glands

Clinical Study of Hypocalcemia following Thyroid Surgery

B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.

Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients

Karoline Nowillo, MD. February 1, 2008

A rare case of solitary toxic nodule in a 3yr old female child a case report

Technetium-99m Sestamibi Scintigraphy Pattern in Patients with Secondary Hyperparathyroidism

ORIGINAL ARTICLE. Persistent Parathyroid Hormone Elevation Following Curative Parathyroidectomy for Primary Hyperparathyroidism

HYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE DIALYSIS THERAPY

Radiographic Appearance Of Primary Hyperparathyroidism With Atypical Parathyroid Adenoma

Thyroid Ultrasound for the Endocrine Surgeon: A Valuable Clinical Tool that Enhances Diagnostic and Therapeutic Outcomes

Case report. Open Access. Abstract

Thyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.

PAPER. The Effectiveness of Radioguided Parathyroidectomy in Patients With Negative Technetium Tc 99m Sestamibi Scans

Optimizing the Minimally Invasive Approach to Mediastinal Parathyroid Adenomas

Post-operative Transient Hypoparathyroidism: Incidence and Risk Factors

SUCCESSFUL IMPLANT OF LONG-TERM CRYOPRESERVED PARATHYROID GLANDS AFTER TOTAL PARATHYROIDECTOMY

Clinical Medicine Insights: Endocrinology and Diabetes 2013:6

Transcription:

Chirurgia (2015) 110: 425-429 No. 5, September - October Copyright Celsius Technical Factors Involved in Parathyroid Surgery M. Dumitras 1, V. Strambu 1, P. A. Radu 1, C. Iorga 1, I. Bengulescu 1, F. Popa 2 1 Department of General Surgery, Carol Davila Nephrology Clinical Hospital, Bucharest, Romania 2 Department of General Surgery, St. Pantelimon Clinical Emercency Hospital, Bucharest, Romania Rezumat Factori tehnici implicaåi în chirurgia paratiroidianã Lucrarea îæi propune investigarea frecvenåei glandelor paratiroide ectopice æi supranumerare în seria noastrã de pacienåi cu hiperparatiroidism renal. Din octombrie 2011 pânã în noiembrie 2014, 202 pacienåi cu insuficienåã renalã cronicã æi SHPT avansat, refractar la tratamentul medicamentos au fost internaåi pe secåia Chirurgie Generalã a Spitalului de Nefrologie Carol Davila. La aceæti pacienåi au fost efectuate 188 paratiroidectomii totale (93%), respectiv 14 paratiroidectomii subtotale (7%) în departamenul nostru. Dintre aceætia, reintervenåia a fost realizatã la 14 pacienåi (7%), la care s-au identificat glande paratiroide ectopice æi supranumerare. Detaliile operatorii æi rezultatele anatomopatologice au fost colectate æi analizate prospectiv dupã ce s-a obåinut consimåãmântul informat al pacienåilor pentru utilizarea datelor æi imaginilor. La 188 din cei 202 pacienåi (93% cazuri), au fost gãsite cel puåin patru sau mai multe glande paratiroide la operaåia iniåialã. În 14 cazuri (7%) nivelul crescut al PTH-ului a persistat postoperator. În 22 cazuri (11%) au fost decelate glande paratiroide supranumerare la operaåia iniåialã æi în 6 cazuri (3%) la a doua intervenåie. În concluzie explorarea cervicalã extensivã în asociere cu o explorare Corresponding author: Marina Dumitras, MD Department of General Surgery Carol Davila Nephrology Hospital 4 Calea Grivitei Street, 1th District 010701, Bucharest, Romania E-mail: marinadumitras@gmail.com imagisticã preoperatorie adecvatã (ecografie paratiroidianã, scintigrafie cu tc sestamibi, CT cervico-mediastinal poate reduce rata recurenåei hiperparatiroidismului secundar. Cuvinte cheie: Hiperparatiroidism secundar, paratiroidectomie, ectopic, supranumerar Abstract We aimed to investigate the frequency of ectopic and supernumerary parathyroid glands in our series of renal hyperparathyroidism. From October 2011 to November 2014, 202 patients with chronic renal failure and advanced SHPT nonresponsive to medical therapy were hospitalized in the General Surgery Department of the Carol Davila Nephrology Hospital. These patients underwent a number of 188 (93%) total parathyroidectomies and a number of 14 patients (7%) subtotal parathyroidectomies. Of these 202 patients, reoperation was carried out for 14 patients (7%) in which we identified ectopic and supernumerary parathyroid glands. Operative details and pathology results were prospectively collected and reviewed after we obtained informed consent for data and pictures use. In 188 patients (93% cases), four or more parathyroid glands were removed at the first operation. In 14 cases (7%) high PTH level persisted after the initial operation. In 22 of them (11%), supernumerary glands were found at the first operation and in 6 of them (3%) at the second operation. We conclude that extensive cervical exploration in addition with preoperative imaging tests, parathyroid ultrasound; scintigraphy with Tc will reduce secondary hyperparathyroidism surgery. Key words: secondary hyperparathyroidism (SHPT), parathyroidectomy, ectopic & supernumerary

426 Introduction It had been demonstrated that 30% are chronically dialyzed patients develop Secondary hyperparathyroidism (SHPT). Surgical therapy is the only viable solution. The aim of this article is to present our experience in SHPT treatment and to investigate the frequency of ectopic parathyroid supernumerary glands located infrathymic, paraesofageal, intrathyroidian. To avoid persistent and recurrent HPTS, all parathyroid glands including supernumerary and ectopically ones should be removed at the initial operation. A missed gland may be an ectopic gland or a very small one. It is well known that chronic renal failure induces SHPT, which is one of the serious complications influencing the mortality and quality of life in patients with chronic renal failure. Despite advances in medical prophylaxis and treatment, in many patients SHPT is refractory to medical treatment such as calcimimetics, new phosphate binders, less calcemic vitamin D analogs. These cases then consequently require parathyroidectomy (1). The incidence of advanced SHPT gradually increases with the duration of hemodialysis treatment. Total parathyroidectomy is the most successful treatment for advanced SHPT and has positive effects on symptoms and biochemistry (1). Subtotal parathyroidectomy and total parathyroidectomy with auto transplantation of parathyroid tissue are currently considered standard surgical procedures, the last procedure being the most successful treatment for advanced SHPT with positive effects on symptoms and biochemistry (1) It is possible that with the ongoing stimulus of renal failure, microscopic rests proliferate over time to manifest later as supernumerary glands serve as a cause of recurrent hyperparathyroidism (9 11). Material and Methods From October 2011 to November 2014, 202 patients with chronic renal failure and advanced SHPT refractory to medical therapy, were hospitalized the General Surgery Department of the Carol Davila Nephrology Hospital. These patients underwent total parathyroidectomies a number of 188 patients (93%) and respectively subtotal parathyroidectomies a number of 14 (7%) patients. Of these 202 patients, reoperation was carried out for 14 (7%) patients in whom we identified ectopic and supernumerary parathyroid glands. Operative details and pathology results were prospectively collected and reviewed after we obtained informed consent for use data and pictures. Results In 188 patients (93%), four or more parathyroid glands were extirpated at the first operation. In all these cases, the intact PTH level dropped under the normal upper limit indicating that an essential hyperplastic parathyroid gland was not left behind (normal range: 10-70 pg/ml). The number of removed gland was confirmed by Table 1. Intervention type Frequency Percent Valid Cumulative Percent Percent Valid PS 14 7 7 7 PT 188 93 93 100.0 Total 202 100.0 100.0 histopathological examination at the initial operation. Intact PTH levels were measured the 1st postoperative day. In 14 patients (7%) who had undergone subtotal parathyroidectomy the fourth parathyroid gland was not found in these cases being necessary a second operation witch detected ectopically parathyroid glands: infrathyimic 4 patients (29%), close to aortic arch, deep within the mediastinum one patient (7%), on the surface of thyroid lobe 5 patients (36%), in paraesofageal fat tissue 4 patients (28%). (Table 1) In 14 cases (7%) high PTH level persisted after the initial operation. In 22 of them (11%), supernumerary glands were found at the first operation and in 6 of them (3%) at the second operation. Subtotal thyroidectomy was necessary in 8 patients (4%) diagnosed with chronic Hashimoto thyroiditis. In order to remove all parathyroid glands, including supernumerary ones, localization by preoperative noninvasive image diagnosis were required the following order Us, S, CT and MRI. All patients demonstrated biochemical criteria of SHPT. They were referred for surgery by the consultant nephrologist. Their data were collected prospectively and stored. In the study, we reviewed the medical records, the anatomic and pathological findings during cervical surgical exploration, together with their pathology reports and outcomes of SHPT during follow-up. We establish an algorithm for brought the surgical indications gathering PTH levels higher than ten times the normal upper limit (normal range: 10-70 pg/ml), for us PTH > 800 pg/ml, osteopathy, osteoporosis, calciphylaxis, calcifications of vessels and soft tissues, fractures in pathological bone, medical history medical treatment administration for a period of six months persistent hypercalcemia and/or hyperphosphatemia (30, 31). There were 91 men (45.05%) and 111 women (54.95%) with mean age of 51.51 years (range: 21 77) (Table 2).The mean ± SD time from the start of dialysis to parathyroidectomy was 7.36 years. In 190 cases (94%) underwent hemodialysis and 12 cases (6%) had peritoneal dialysis (Table 3). The mean ± SD of intact pre operatory PTH was 1684.20 (range: 355-4120 pg/ml) and intact post operatory was 98.47 (range: 3-985 pg/ml) (Table 4, Table 5). All surgical procedures were performed under general anesthesia. In addition, since small rudimentary microscopic glands may be concealed in fat, the tissue surrounding the Table 2. Sex distribution Frequency Percent Valid Male 91 45.05 Female 111 54.95 Total 202 100.0

427 Table 3. Dialysis type Frequency Percent Valid Cumulative Percent Percent Valid Peritoneal dialysis 12 6 6 6 hemodialysis 190 94 94 100.0 Total 202 100.0 100.0 glands was routinely excised (32). In patients with less than four parathyroid glands identified extensive neck exploration was routinely performed. The pathology results certificated nodular hyperplasia in 9 patients (4% of cases), diffuse hyperplasia in 103 patients (51% of cases) and mixed hyperplasia in 70 patients (35% of cases). Mixed hypertrophy was found in 20 patients (10% of cases) (Figs 1, 2, 3). In addition to parathyroid glands the fat, thymus and thyroid resected specimens were sent for histological examination. Thymus, adipose tissue, lymph nodes, thyroid and other specimens were fixed in buffered 10 % formaldehyde, embedded in paraffin and sectioned serially at 5 μm. The sections were stained with hematoxylineosin. Microscopic slides were examined at X20 to X200 magnifications under the light microscope by the same pathologist. Reoperation was carried out in 14 patients with persistent HPT related to parathyroid remnants. In a patient with persistent HPT, the remnant was removed and parathyroid tissue which was implanted into the anterior cervical region in selective cases. Supernumerary parathyroid glands (14%) were responsible for recurrent HPT. The hyperplastic supernumerary gland and remnant were resected and the parathyroid tissue was transplanted into the cervical region. Discussion The optimal surgical treatment in patients with refractory renal hyperparathyroidism (RHP) on hemodialysis for end stage renal disease is still a point of controversy (28). It should be acknowledged that due to the complex Table 4. Pre operatory PTH N Valid 202 Missing 0 Mean 1684.20 Median 1585.00 Mode 1450 a Std. Deviation 514.736 Minimum 355 Maximum 4120 Figure 2. Nodular hyperplasia Table 5. Post operatory PTH N Valid 202 Missing 0 Mean 98.4748 Median 30.6500 Mode 3.00 Std. Deviation 168.58461 Minimum 3.00 Maximum 985.00 Figure 3. Diffuse hyperplasia Figure 1. Mixed hyperplasia development during embryogenesis the parathyroid gland may be located ectopically. When overlooked during parathyroidectomy, the ectopic gland may cause persistent or recurrent hyperparathyroidism. Anomalies in the location of parathyroid glands, particularly in that of inferior ones are not rare. Autopsy examinations indicate that the percentage of cases with less than four parathyroid glands is 3.65 to 19% (2-6) The inferior parathyroid glands and the thymus arise from the embryonic third pharyngeal pouch During the course of normal development, the complex

428 of the inferior gland and thymus migrate through the entire extent of the embryonic neck. Because of this embryologic relation of inferior parathyroid with the thymus, a missing lower gland is most likely to be found in the thymus (12, 21, 22). Uno et al (5) noted that in cases with renal hyperparathyroidism, 29.8 % of patients had only inferior glands and 8.6 % of patients had either inferior and supernumerary glands detected infrathymic or paraesofageal. Based on 160 autopsies, Wang (8) reported that the frequency of supernumerary and ectopic parathyroid glands was 41%. Also in 503 autopsies, Akerstrom et al (7) demonstrated that at least 13 % of all normal persons have supernumerary and ectopic parathyroid glands, half of which should be proper ones while the other half are rudimentary islets of parathyroid tissue. Hyperplasia of all parathyroid tissues including microscopic rests develops as a result of continued parathyroid stimulation by chronic renal failure, possibly because hyperplastic glands can be recognized easier (13, 23). Thus, the supernumerary and ectopic glands are more important in SHPT than in primary HPT (15, 16). The incidence of supernumerary and ectopic glands has been reported to be 10-30% in patients who underwent parathyroidectomy for SHPT (3, 5, 6, 17). The most frequent location of supernumerary and ectopic parathyroid tissue in autopsy series was in the thymic tongue, thyroid gland, carotid sheath, paraesofageal, mediastinum and paratracheal (3, 6, 24). Numano et al (3) detected supernumerary and ectopic glands in 16.5 % of patients who under-went parathyroidectomy for SHPT while 51 % of those glands were located infratimic, intrathyroid. Both subtotal parathyroidectomy and total parathyroidectomy with or without auto transplantation are accepted operations for SHPT. Total parathyroidectomy with auto transplantation is the best procedure for treating recurrences but the increased risk of hypoparathyroidism must be kept in mind (1, 3, 21, 17, 19, 20). Based on 53 publications in literature, Richards et al (18) reviewed 501 patients who had undergone a reoperation for persistent or recurrent SHPT. They identified reported a significantly higher rate of recurrent SHPT in patients with auto grafts than in those with in situ remnants (49 % vs 17 %) (18). Although the most common causes for recurrence include hyperplasia of the subtotal remnant or auto graft in SHPT, supernumerary and ectopic glands and account for up to 32 % of recurrences (6, 18). In both subtotal parathyroidectomy and total parathyroidectomy with auto transplantation, it is very important to identify all parathyroid glands including supernumerary and ectopic glands at the initial operation (3, 6). In SHPT, the stimuli of the parathyroid cells persist after initial parathyroidectomy, leading to enlargement of small glands and parathyroid rests for long periods; therefore the rudimentary islets of parathyroid tissue in SHPT become important (10, 25). It has been observed that following total parathyroidectomy aimed at removing all macroscopic parathyroid tissue, plasma parathyroid hormone initially falls to undetectable concentrations but subsequently rises again with time (26, 27). This supports the presence of microscopic residual parathyroid rests able to respond to a stimulation of renal failure. Although they are missed, supernumerary and ectopic parathyroid glands are usually small, and may gradually enlarge due to continuous stimulation. Thus, a removal may be required during the long-term follow-up period (21). Uno et al (5) reported that the incidence of patients with infrathymic, intrathyroid, paraesofageal, paratraheal parathyroid glands was 45.3 %. In our study extensive cervical neck exploration contributed to the treatment of about 93 % of patients. Parathyroidectomy is effective for long intervals as symptomatic therapy in cases of RHPT appearing in uremic patients on hemodialysis or after renal transplant but the optimal technique must be individualized on each case and still to be debated (29). Conclusions We conclude that in order to minimize the risk of missing parathyroid glands, extensive cervical bilateral neck exploration in addition with superior mediastinum remains the prerogative of collective surgical involved in SHPT and the parathyroidectomy is the only curative therapy. References 1. Tominaga Y. Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease. Ups J Med Sci 2006; 111 (3): 277 292. 2. Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan. Report of the JSDT, 1998. 3. Numano M, Tominaga Y, Uchida K, Orihara A, Tanaka Y, Takagi H. Surgical significance of supernumerary parathyroid glands in renal hyperparathyroidism. World J Surg 1998; 22 (10): 1098 1102. 4. Edis AJ, Levitt MD. Supernumerary parathyroid glands: implications for the surgical treatment of secondary hyperparathyroidism. World J Surg 1987; 11 (3): 398 401. 5. Uno N, Tominaga Y, Matsuoka S. Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism. World J Surg 2008; 32 (11): 2516 6. Pattou FN, Pellissier LC, Noël C, Wambergue F, Huglo DG, Proye CA. Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism World J Surg 2000; 24 (11): 1330 1334. 7. Akerström G, Malmaeus J, Bergström R. Surgical anatomy of human parathyroid glands. Surgery 1984; 95 (1): 14 21. 8. Wang C. The anatomic basis of parathyroid surgery. Ann Surg 1976; 183 (3): 271 275. 9. Aly A, Douglas M. Embryonic parathyroid rests occur commonly and have implications in the management of secondary hyperparathyroidism. ANZ J Surg 2003; 73 (5): 284 288. 10. Tominaga Y, Katayama A, Sato T, Matsuoka S, Goto N, Haba T et al. Reoperation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced

429 secondary hyperparathyroidism in uremic patients. Nephrol Dial Transplant 2003; 18 (Suppl 3): iii65 70. 11. Matsuoka S, Tominaga Y, Sato T, Uno N, Goto N, Katayama A et al. Recurrent renal hyperparathyroidism caused by parathyromatosis. World J Surg 2007; 31 (2): 299 305. 12. Gilmour JR. The gross anatomy of the parathyroid glands. J Pathol Bacteriol 1938; 46: 133 149. 13. Thompson NW, Eckhauser FE, Harness JK. The anatomy of primary hyperparathyroidism. Surgery 1982; 92 (5): 814 821. 14. Tsuchiya M, Kamegaya K, Shimabukuro K, Takagi K, Yoshimatsu H. Intrathymic parathyroid tissue in man: clinical significance and report of a case of intrathymic parathyroid adenoma. Keio J Med 1971 (1); 20: 91 102. 15. Nobori M, Saiki S, Tanaka N, Harihara Y, Shindo S, Fujimoto Y. Blood supply of the parathyroid gland from the superior thyroid arte-ry. Surgery 1994; 115 (4): 417 423. 16. Muirhead N, Thorning D, Sherrard D. Secondary hyperparathyroidism complicated by parathyromatosis. Am J Kidney Dis 1996; 28 (4): 502 507. 17. Proye C, Carnaille B, Sautier M. Hyperparathyroidism in patients with chronic renal failure: subtotal parathyroidectomy or total parathyroidectomy with autotransplantation? Experience with 121 cases. J Chir (Paris) 1990; 127 (3): 136 140. 18. Richards ML, Wormuth J, Bingener J, Sirinek K. Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management? Surgery 2006; 139 (2): 174 180. 19. Gasparri G, Camandona M, Abbona GC, Papotti M, Jeantet A, Radice E et al. Secondary and tertiary hyperparathyroidism: Causes of recurrent disease after 446 parathyroidectomies. Ann Surg 2001; 233 (1): 65 69. 20. Barbaros U, Erbil Y, Yildirim A, Saricam G, Yazici H, Ozarmagan S. Minimally invasive video-assisted subtotal parathyroidectomy with thymectomy for secondary hyperparathyroidism. Langenbecks Arch Surg 2009; 394 (3): 451 455. 21. Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, Hibi Yn et al. More than 1,000 cases of total parathyroidectomy with forearm auto graft for renal hyperparathyroidism. Am J Kidney Dis 2000; 38(4 Suppl 1): S168 S171. 22. Kaczirek K, Prager G, Riss P, Wunderer G, Asari R, Scheuba C et al. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.arch Surg 2006; 141 (2): 129 134. 23. Cheng SP, Liu CL, Chen HH, Lee JJ, Liu TP, Yang TL. Prolonged hospital stay after parathyroidectomy for secondary hyperparathyroidism. World J Surg 2009; 33 (1): 72 79. 24. Zou Q, Wang HY, Zhou J, Lao ZY, Xue J, Li MX et al. Total parathyroidectomy combined with partial auto-transplantation for the treatment of secondary hyperparathyroidism. Chin Med J (Engl) 2007; 120 (20): 1777 1782. 25. Slatopolsky E. The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism. Nephrol Dial Transplant 1998; 13 Suppl 3: s3 s8. 26. Lorenz K, Ukkat J, Sekulla C, Gimm O, Brauckhoff M, Dralle H. Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qpthcontrolled protocol. World J Surg 2006; 30 (5): 743 751. 27. Saunders RN, Karoo R, Metcalfe MS, Nicholson ML. Four gland parathyroidectomy without preimplantation in patients with chronic renal failure. Postgrad Med J 2005; 81 (954): 255 258. 28. Diaconescu MR, Glod M, Costea I, Grigorovici M, Diaconescu S. Total parathyroidectomy without autotransplantation in the management of "refractory" renal hyperparathyroidism. Medico- Surgical Society of Physicians and Naturalists Journal of Iasi [2011, 115(1):105-110] 29. Diaconescu MR, Glod M, Costea I, Grigorovici M, Covic A, Diaconescu S. Surgical management of renal hyperparathyroidism. Official Journal of the Romanian Society of Surgery (Bucharest, Romania: 1990) [2011, 106(1):51-57] 30. Mircescu G, Stanescu B. Surgical or medical therapy for severe hyperparathyroidism of chronic kidney disease. Acta Endocrinologica (Buc), vol. VI, no. 4, p. 541-576, 2010 31. Diaconescu MR, Costea I, Terinte R, Diaconescu S, Covic M, Zbranca E. Secondary hyperparathyroidism. Official Journal of the Romanian Society of Surgery (Bucharest, Romania: 1990) [1995, 44(1):27-34] 32. Neagoe RM, Sala DT, Roman V, Voidazan S, Pascanu I. Subtotal parathyroidectomy in the treatment of renal hyperparathyroidism. Acta Endocrinologica (Buc), vol. IX, no. 3, p. 385-396, 2013